ArticlePloS one2012
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors.
Valeria Cento et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papertrialcites it